STRUCTURE AND FUNCTION OF HUMAN SECRETORY COMPONENT
人体分泌成分的结构和功能
基本信息
- 批准号:3131511
- 负责人:
- 金额:$ 17.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-07-01 至 1991-08-31
- 项目状态:已结题
- 来源:
- 关键词:affinity chromatography antibody receptor autoradiography chemical binding chemical structure function child (0-11) conformation enzyme linked immunosorbent assay epithelium gel electrophoresis gene expression genetic library glycoproteins high performance liquid chromatography human milk human subject immunoglobulin A laboratory mouse laboratory rabbit monoclonal antibody nucleic acid probes phosphorylation protease inhibitor protein sequence proteolysis radiotracer receptor mediated endocytosis secretory immune system steroid hormone transposon /insertion element
项目摘要
The goal of this study is to evaluate the contribution of the
epithelial cell to the formation of secretory immunoglobulins
(Ig's), which protect the mucosal surfaces of the body. Our work
is focused on the human polymeric Ig receptor (PIgR) pathway,
which transports polymeric Ig's across epithelial cells and
enchances their secretory function. Recent studies have defined
the protein sequence and Ig-like domain structure of PIgR and its
cleavage product, secretory component (SC), the primary
molecules which mediate the conversion of polymeric Ig into
secretory Ig.
Using a unique panel of monoclonal antibodies which bind to
human SC, secretory IgA and tryptic fragments of these
molecules, we have developed a hypothetical model for the three
dimensional structure of PIgR/SC and its molecular interactions
with the polymeric Ig's. The model provides a useful conceptual
structure for designing experiments with these antibodies and
PIgR cDNA probes to examine the relationship between the
structure and function of the various molecular forms of PIgR/SC.
We will test the following research hypotheses: 1) The multiple
functions of human PIgR and SC are mediated by the structure of
specific Ig-like domains of these glycoproteins; and 2) Modulation
occurs at several sites in the human PIg/SC pathway. We will
biochemically characterize the structures of human PIgR and SC
that are responsible for Ig binding, transcrytosis, and proteolytic
protection. Our second hypothesis will explore potential sites for
regulation or modulation of secretory immunoglobulin production
in epithelial cells.
The physiological significance in humans of these mechanisms will
be explored. Human biological fluids, tissue extracts and thin
sections, cultured cells and products of cloned DNA will provide
complementatry model systems for examination of the human
PIgR/SC pathway from several perspectives. By characterizing
the structural and physiological requirements for SIg formation in
humans, and identifying mechanisms which may modulate this
system, these studies should help to elucidate the molecular and
cellular basis for epithelial cell contributions to mucosal
immunity. This information may be useful in identifying
pathologic abnormalities in the system and designing therapeutic
interventions for mucosal infections and/or diagnostic methods
for early epithelial malignancies.
这项研究的目的是评估的贡献,
上皮细胞分泌免疫球蛋白的形成
(Ig的),其保护身体的粘膜表面。 我们的工作
集中于人聚合物IG受体(PIgR)途径,
它将多聚IG's转运穿过上皮细胞,
增强其分泌功能。 最近的研究表明,
PIgR蛋白质序列和Ig样结构域结构及其
裂解产物,分泌成分,初级
介导聚合物IG转化为
分泌型IG。
使用一组独特的单克隆抗体,
人SC、分泌型伊加和这些的胰蛋白酶片段
分子,我们已经开发了一个假设的模型,为三个
PIgR/SC的空间结构及其分子间相互作用
与聚合物IG的。 该模型提供了一个有用的概念
用于设计这些抗体的实验的结构,
PIgR cDNA探针,以检查
PIgR/SC的各种分子形式的结构和功能。
我们将测试以下研究假设:1)多重
人PIgR和SC的功能由以下结构介导:
这些糖蛋白的特异性Ig样结构域;和2)调节
发生在人Pig/SC途径的几个位点。 我们将
生物化学表征人PIgR和SC的结构
负责IG结合、转胞吞和蛋白水解
保护 我们的第二个假设将探索潜在的网站,
分泌性免疫球蛋白产生的调节或调节
在上皮细胞中。
这些机制在人类中的生理意义将
被探索。 人体生物体液、组织提取物和稀释液
切片、培养细胞和克隆DNA产物将提供
用于人体检查的互补模型系统
PIgR/SC通路从几个角度。 通过表征
免疫球蛋白形成的结构和生理要求,
人类,并确定可能调节这一机制
系统,这些研究应有助于阐明分子和
上皮细胞对粘膜上皮细胞增殖的细胞基础
免疫力 这些信息可能有助于识别
系统中的病理异常和设计治疗
粘膜感染的干预和/或诊断方法
用于早期上皮恶性肿瘤
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Randall M Goldblum其他文献
IMMUNE HEMOLYTIC ANEMIA AFTER BONE MARROW TRANSPLANTATION FOR SEVERE COMBINED IMMUNODEFICIENCY
- DOI:
10.1203/00006450-198704010-00866 - 发表时间:
1987-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Diane Foster;Robert J Mamlok;Fatih Ozkaragoz;Christopher Leveque;Armond S Goldman;Randall M Goldblum - 通讯作者:
Randall M Goldblum
Human Milk Feeding Enhances the Urinary Excretion of Immunologic Factors in Low Birth Weight Infants
母乳喂养可增强低出生体重婴儿免疫因子的尿排泄
- DOI:
10.1203/00006450-198902000-00021 - 发表时间:
1989-02-01 - 期刊:
- 影响因子:3.100
- 作者:
Randall M Goldblum;Richard J Schanler;Cutberto Garza;Armond S Goldman - 通讯作者:
Armond S Goldman
856 CORRECTION OF CHRONIC GRANULOMATOUS DISEASE (CDG) BY BONE MARROW TRANSPLANTATION (BMT)
856 骨髓移植(BMT)对慢性肉芽肿病(CDG)的纠正
- DOI:
10.1203/00006450-198104001-00881 - 发表时间:
1981-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Joel M Rappeport;Peter Newburger;Armond Goldman;Randall M Goldblum;Robertson Parkman - 通讯作者:
Robertson Parkman
919 ALTERATIONS IN IMMUNOLOGIC FACTORS IN HUMAN MILK DURING LACTATION
- DOI:
10.1203/00006450-198104001-00944 - 发表时间:
1981-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Randall M Goldblum;Cutberto Garza;Buford L Nichols;Armond S Goldman - 通讯作者:
Armond S Goldman
598 FOOD PROTEIN-INDUCED ENTEROCOLITIS: DETECTION OF ORALLY INGESTED ANTIGEN IN SERUM AND URINE
- DOI:
10.1203/00006450-198104001-00611 - 发表时间:
1981-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Philip McDonald;Geraldine K Powell;Randall M Goldblum - 通讯作者:
Randall M Goldblum
Randall M Goldblum的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Randall M Goldblum', 18)}}的其他基金
Prevention of Allergic Rhinitis with Topical Immunomodulating Antibodies
使用外用免疫调节抗体预防过敏性鼻炎
- 批准号:
8201881 - 财政年份:2011
- 资助金额:
$ 17.21万 - 项目类别:
Phylogenetic Approach to Plant Allergy Vaccines
植物过敏疫苗的系统发育方法
- 批准号:
7760239 - 财政年份:2009
- 资助金额:
$ 17.21万 - 项目类别:
Phylogenetic Approach to Plant Allergy Vaccines
植物过敏疫苗的系统发育方法
- 批准号:
6861095 - 财政年份:2004
- 资助金额:
$ 17.21万 - 项目类别:
Phylogenetic Approach to Plant Allergy Vaccines
植物过敏疫苗的系统发育方法
- 批准号:
7029666 - 财政年份:2004
- 资助金额:
$ 17.21万 - 项目类别:
Phylogenetic Approach to Plant Allergy Vaccines
植物过敏疫苗的系统发育方法
- 批准号:
7225584 - 财政年份:2004
- 资助金额:
$ 17.21万 - 项目类别:
Phylogenetic Approach to Plant Allergy Vaccines
植物过敏疫苗的系统发育方法
- 批准号:
6723560 - 财政年份:2004
- 资助金额:
$ 17.21万 - 项目类别:
相似海外基金
Study on the mechanism of prolonged half-life of blood IgY by unique antibody receptor and its application to immune enhancement in birds
独特抗体受体延长血液IgY半衰期的机制研究及其在禽类免疫增强中的应用
- 批准号:
23H02361 - 财政年份:2023
- 资助金额:
$ 17.21万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : GNT1124162 - 财政年份:2017
- 资助金额:
$ 17.21万 - 项目类别:
Early Career Fellowships
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : 1124162 - 财政年份:2017
- 资助金额:
$ 17.21万 - 项目类别:
Early Career Fellowships
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9300976 - 财政年份:2015
- 资助金额:
$ 17.21万 - 项目类别:
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9920805 - 财政年份:2015
- 资助金额:
$ 17.21万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8900121 - 财政年份:2012
- 资助金额:
$ 17.21万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8225814 - 财政年份:2012
- 资助金额:
$ 17.21万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8699511 - 财政年份:2012
- 资助金额:
$ 17.21万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8525355 - 财政年份:2012
- 资助金额:
$ 17.21万 - 项目类别:
Small Grants for Exploratory Research: Separation of Cells and Biological Macromolecules by Antibody Receptor Coated Magnetic Vesicles and Ferritin Conjugates
探索性研究小额资助:通过抗体受体包被的磁囊和铁蛋白缀合物分离细胞和生物大分子
- 批准号:
9115537 - 财政年份:1991
- 资助金额:
$ 17.21万 - 项目类别:
Standard Grant